Clinical Trial: Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC
Study Status: Completed
Recruit Status: RECRUITING
Condition: NSCLC Stage IV
Study Type: INTERVENTIONAL
Official Title: A Phase II Trial of Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC
Brief Summary:
The purpose of this study is to test if low dose radiation, which is routinely used in treating patients with lung cancer for symptom control, can improve the results from the standard treatment with pembrolizumab and chemotherapy.In this study, only individuals who have NSCLC that is advanced (Stage IV), or has come back (recurred), will be able to participate.
Read more